Ruoning Wang

1.9k total citations · 1 hit paper
48 papers, 1.5k citations indexed

About

Ruoning Wang is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Ruoning Wang has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Biomedical Engineering and 13 papers in Biomaterials. Recurrent topics in Ruoning Wang's work include Extracellular vesicles in disease (19 papers), Nanoplatforms for cancer theranostics (17 papers) and Nanoparticle-Based Drug Delivery (13 papers). Ruoning Wang is often cited by papers focused on Extracellular vesicles in disease (19 papers), Nanoplatforms for cancer theranostics (17 papers) and Nanoparticle-Based Drug Delivery (13 papers). Ruoning Wang collaborates with scholars based in China, United States and Australia. Ruoning Wang's co-authors include Liuqing Di, Junsong Li, Yang Ding, Jianping Zhou, Jinge Li, Yaw Opoku‐Damoah, Wei Zeng, Xue Wang, Honglan Wang and Jianping Zhou and has published in prestigious journals such as Nature Communications, Nano Letters and ACS Nano.

In The Last Decade

Ruoning Wang

48 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood–Brain Barrier for Chemo-immunotherapy against Glioblastoma

2023 171 citations Jinge Li, Wei Zeng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruoning Wang China	24	774	449	406	215	126	48	1.5k
Linwei Lu China	20	738 1.0×	528 1.2×	555 1.4×	111 0.5×	150 1.2×	42	1.4k
Kosuke Shimizu Japan	27	982 1.3×	386 0.9×	585 1.4×	184 0.9×	156 1.2×	89	1.9k
Shaofeng Duan China	27	792 1.0×	488 1.1×	338 0.8×	159 0.7×	148 1.2×	84	1.9k
Xingmei Duan China	26	847 1.1×	280 0.6×	341 0.8×	104 0.5×	235 1.9×	56	1.7k
Huae Xu China	27	918 1.2×	623 1.4×	558 1.4×	200 0.9×	155 1.2×	70	2.1k
Jianping Zhou China	29	907 1.2×	674 1.5×	801 2.0×	212 1.0×	117 0.9×	62	2.2k
Fanzhu Li China	24	614 0.8×	525 1.2×	509 1.3×	97 0.5×	125 1.0×	81	1.7k
Chaemin Lim South Korea	18	548 0.7×	275 0.6×	360 0.9×	141 0.7×	95 0.8×	71	1.3k

Countries citing papers authored by Ruoning Wang

Since Specialization

Citations

This map shows the geographic impact of Ruoning Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoning Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoning Wang more than expected).

Fields of papers citing papers by Ruoning Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruoning Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoning Wang. The network helps show where Ruoning Wang may publish in the future.

Co-authorship network of co-authors of Ruoning Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruoning Wang. A scholar is included among the top collaborators of Ruoning Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoning Wang. Ruoning Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xue, Wenjing Chen, Wei Zeng, et al.. (2025). Extracellular vesicles as biomarkers and drug delivery systems for tumor. Acta Pharmaceutica Sinica B. 15(7). 3460–3486. 2 indexed citations

Roth, Sydney L., Minu Samanta, Guillem Pascual‐Pasto, et al.. (2025). Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells. Molecular Therapy. 33(9). 4552–4569. 3 indexed citations

He, Yanyi, Chenxi He, Qiuyue Zhang, et al.. (2025). Advances in the structures, mechanisms and targeting of molecular chaperones. Signal Transduction and Targeted Therapy. 10(1). 84–84. 13 indexed citations

Wang, Xue, Hanwen Zhang, Yingjie Zhang, et al.. (2025). Intranasal hybrid vesicles delivering personalized in situ nano-vaccines induce glioblastoma remodeling to sensitize immunotherapy. Nano Today. 65. 102840–102840. 3 indexed citations

Bao, Rongrong, Jiaxin Guo, Wenjing Chen, et al.. (2025). Engineered plant extracellular vesicles: Emerging nanoplatforms for combinational cancer immunotherapy. Acta Pharmaceutica Sinica B. 15(11). 5663–5701. 1 indexed citations

Chen, Wenjing, et al.. (2024). Nasal administration of Xingnaojing biomimetic nanoparticles for the treatment of ischemic stroke. International Journal of Pharmaceutics. 666. 124830–124830. 2 indexed citations

Chen, Xiaojin, et al.. (2024). Tumor Metabolism: A New Field for the Treatment of Glioma. Bioconjugate Chemistry. 35(8). 1116–1141. 3 indexed citations

Pan, L Y, Jiale Li, Yao Huang, et al.. (2024). Cell inspired delivery system equipped with natural membrane structures in applications for rescuing ischemic stroke. Journal of Controlled Release. 377. 54–80. 4 indexed citations

Wang, Ruoning, et al.. (2023). Bio-fabricated nanodrugs with chemo-immunotherapy to inhibit glioma proliferation and recurrence. Journal of Controlled Release. 354. 572–587. 26 indexed citations

10.

Wang, Ruoning, Yingjie Zhang, Wei Zeng, et al.. (2023). Plant-derived nanovesicles: Promising therapeutics and drug delivery nanoplatforms for brain disorders. Fundamental Research. 5(2). 830–850. 18 indexed citations

11.

Xu, Yuanxin, et al.. (2022). Mineral medicine: from traditional drugs to multifunctional delivery systems. Chinese Medicine. 17(1). 21–21. 21 indexed citations

12.

Wang, Ruoning, et al.. (2022). Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment. Colloids and Surfaces B Biointerfaces. 215. 112505–112505. 49 indexed citations

13.

Xu, Yuanxin, et al.. (2021). Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas. Acta Pharmaceutica Sinica B. 12(3). 1100–1125. 33 indexed citations

14.

Wang, Ruoning, Yujie Yang, Mengmeng Yang, et al.. (2020). Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions. Journal of Nanobiotechnology. 18(1). 116–116. 37 indexed citations

15.

Wang, Ruoning, et al.. (2020). Impacts of particle size on the cytotoxicity, cellular internalization, pharmacokinetics and biodistribution of betulinic acid nanosuspensions in combined chemotherapy. International Journal of Pharmaceutics. 588. 119799–119799. 24 indexed citations

16.

Wang, Ruoning, Chenshuang Zhang, Junsong Li, et al.. (2019). Laser-triggered polymeric lipoproteins for precision tumor penetrating theranostics. Biomaterials. 221. 119413–119413. 23 indexed citations

17.

Wang, Ruoning, Jiawei Han, Rong Huang, et al.. (2019). Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine. International Journal of Pharmaceutics. 561. 9–18. 95 indexed citations

18.

Opoku‐Damoah, Yaw, Ruoning Wang, Jianping Zhou, & Yang Ding. (2016). Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing. Theranostics. 6(7). 986–1003. 44 indexed citations

19.

Chen, Tong, Ruoning Wang, Wenjiao Jiang, et al.. (2015). Protective Effect of Astragaloside IV Against Paraquat-Induced Lung Injury in Mice by Suppressing Rho Signaling. Inflammation. 39(1). 483–492. 114 indexed citations

20.

Ding, Yang, Wei Wang, Meiqing Feng, et al.. (2012). A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy. Biomaterials. 33(34). 8893–8905. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linwei Lu Breakdown of academic impact, for papers by Kosuke Shimizu Breakdown of academic impact, for papers by Shaofeng Duan Breakdown of academic impact, for papers by Xingmei Duan Breakdown of academic impact, for papers by Huae Xu Breakdown of academic impact, for papers by Jianping Zhou Breakdown of academic impact, for papers by Fanzhu Li Breakdown of academic impact, for papers by Chaemin Lim